Glycosphingolipid synthesis mediates immune evasion in KRAS-driven cancerMariluz Soula, Kıvanç Birsoy|Nature|2024Cited by 78
Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosisElena M. Kaftanovskaya, Alexander I. Agoulnik, Marc Ferrer et al.|The FASEB Journal|2019Cited by 35
Human Relaxin Receptor Is Fully Functional in Humanized Mice and Is Activated by Small Molecule Agonist ML290Elena M. Kaftanovskaya, Alexander I. Agoulnik, Mariluz Soula et al.|Journal of the Endocrine Society|2017Cited by 24
Anti-apoptotic and Matrix Remodeling Actions of a Small Molecule Agonist of the Human Relaxin Receptor, ML290 in Mice With Unilateral Ureteral ObstructionHooi Hooi Ng, Alexander I. Agoulnik, Mariluz Soula et al.|Frontiers in Physiology|2021Cited by 2
Small molecule allosteric agonist of relaxin receptor ML290 demonstrates antifibrotic properties in liver fibrosisElena M. Kaftanovskaya, Alexander I. Agoulnik, Hooi Hooi Ng et al.|Endocrine Abstracts|2019Cited by 1